United States Department of Labor

Employees’ Compensation Appeals Board

__________________________________________

J.M., Appellant

and

U.S. POSTAL SERVICE, POST OFFICE, 

Palatine, IL, Employer

__________________________________________

)

)

)

)

)

)

)

)

Docket No. 20-0457

Issued: July 16, 2020

Appearances: Case Submitted on the Record

Appellant, pro se

Office of Solicitor, for the Director

DECISION AND ORDER

Before:

ALEC J. KOROMILAS, Chief Judge

JANICE B. ASKIN, Judge

PATRICIA H. FITZGERALD, Alternate Judge

JURISDICTION

On December 29, 2019 appellant filed a timely appeal from a December 19, 2019 merit 

decision of the Office of Workers’ Compensation Programs (OWCP). Pursuant to the Federal 

Employees’ Compensation Act1(FECA) and 20 C.F.R. §§ 501.2(c) and 501.3, the Board has 

jurisdiction to consider the merits of this case.

ISSUE

The issue is whether OWCP abused its discretion in denying authorization for a pulsed

electromagnetic field (PEMF) therapy device.

 

1 5 U.S.C. § 8101 et seq.
2

FACTUAL HISTORY

On December 1, 2018 appellant, then a 58-year-old letter carrier, filed a traumatic injury 

claim (Form CA-1) alleging that on November 28, 2018 he injured his right hand when he broke 

a seal of ice on a mailbox while in the performance of duty. He stopped work on the date of injury.

On December 20, 2018 OWCP accepted appellant’s claim for the contusion of the right 

hand and aggravation of right carpal tunnel syndrome. On January 25, 2019 appellant underwent 

an authorized right carpal tunnel release, which was performed by Dr. Eugene P. Lopez, an 

attending Board-certified orthopedic surgeon. OWCP paid wage-loss compensation on the 

supplemental rolls, as of January 14, 2019, and on the periodic rolls as of March 31, 2019.

Appellant returned to full-time, full-duty work without restrictions on May 14, 2019. 

In an October 14, 2019 medical report, Dr. Lopez noted that there had been no significant 

changes in his right wrist symptoms; however, appellant indicated that he still had pain at times, 

mostly after work. On examination of the right wrist, he found a well-healed surgical scar, no 

swelling, deformity, or tenderness, improving range of motion, 5/5 strength, and an intact 

neurovascular examination. Dr. Lopez provided an impression of eight and one-half months status 

post right carpal tunnel release. He recommended a home exercise program and prescribed a 

PEMF therapy device. Dr. Lopez certified that the device was medically indicated and opined that 

it was reasonable and necessary for the treatment of appellant’s condition. He related that the 

device was also for the management of pain, inflammation, and swelling. Dr. Lopez expected that 

its use would accelerate appellant’s recovery and decrease the use of pain medication. He

concluded that appellant may return to regular-duty work without restrictions. In a prescription 

dated October 14, 2019, Dr. Lopez requested authorization for the PEMF therapy device for 

appellant’s hand/wrist.

On November 19, 2019 OWCP requested that its district medical adviser (DMA) review a 

statement of accepted facts (SOAF) and the medical record, and provide an opinion regarding the 

medical necessity of the PEMF therapy device requested by Dr. Lopez.

In a December 9, 2019 letter, Dr. Nathan Hammel, a Board-certified orthopedic surgeon, 

serving as the DMA, indicated that he had reviewed the SOAF and the medical record, including

Dr. Lopez’s October 14, 2019 report. He acknowledged that the requested treatment was intended 

to treat the accepted condition of carpal tunnel syndrome. However, the DMA advised that the 

requested device was not supported by evidenced-based guidelines. He noted that there was no 

indication that it would decrease pain or increase function. The DMA opined that the requested 

device was not medically necessary. He reasoned that Dr. Lopez documented no objective deficit 

which warranted additional treatment. The DMA indicated that he found no swelling, tenderness, 

or weakness. He concluded that no additional treatment was needed.

By decision dated December 19, 2019, OWCP denied authorization for the PEMF therapy 

device. It found that the opinion of its DMA constituted the weight of the medical evidence and 

established that the requested medical device was not medically necessary to address the effects 

of appellant’s accepted employment-related conditions.
3

LEGAL PRECEDENT

Section 8103(a) of FECA provides that the United States shall furnish to an employee who 

is injured while in the performance of duty, the services, appliances, and supplies prescribed or 

recommended by a qualified physician, which OWCP considers likely to cure, give relief, reduce 

the degree, or the period of disability, or aid in lessening the amount of monthly compensation.2 

While OWCP is obligated to pay for treatment of employment-related conditions, the employee 

has the burden of proof to establish that the expenditure is incurred for treatment of the effects of 

an employment-related injury or condition.3

Section 10.310(a) of OWCP’s implementing regulations provide that an employee is 

entitled to receive all medical services, appliances, or supplies which a qualified physician 

prescribes or recommends and which OWCP considers necessary to treat the work-related injury.4

In interpreting section 8103 of FECA, the Board has recognized that OWCP has broad 

discretion in approving services provided, with the only limitation on OWCP’s authority being 

that of reasonableness.5 OWCP has the general objective of ensuring that an employee recovers 

from his or her injury to the fullest extent possible, in the shortest amount of time. It therefore has 

broad administrative discretion in choosing means to achieve this goal.6

Abuse of discretion is generally shown through proof of manifest error, clearly 

unreasonable exercise of judgment, or actions taken which are contrary to both logic and probable 

deductions from established facts. It is not enough to merely show that the evidence could be 

construed so as to produce a contrary factual conclusion.7

ANALYSIS

The Board finds that OWCP did not abuse its discretion in denying authorization for a 

PEMF therapy device.

OWCP accepted that appellant sustained a contusion of the right hand and aggravation of 

right carpal tunnel syndrome due to a November 28, 2018 employment injury. Appellant 

underwent authorized right carpal tunnel release on January 25, 2019. 

 

2

Id. at § 8103; see D.S., Docket No. 18-0353 (issued May 18, 2020); L.D., 59 ECAB 648 (2008).

3 M.P., Docket No. 19-1557 (issued February 24, 2020); M.B., 58 ECAB 588 (2007).

4 20 C.F.R. § 10.310(a); see D.W., Docket No. 19-0402 (issued November 13, 2019).

5 B.I., Docket No. 18-0988 (issued March 13, 2020); see also Daniel J. Perea, 42 ECAB 214, 221 (1990) (holding 

that abuse of discretion by OWCP is generally shown through proof of manifest error, clearly unreasonable exercise 

of judgment, or administrative actions which are contrary to both logic, and probable deductions from established 

facts).

6 D.S., supra note 2.

7

Id.; L.W., 59 ECAB 471 (2008).
4

Appellant’s treating physician, Dr. Lopez, thereafter sought authorization for a PEMF 

therapy device. He maintained that the device was necessary for the management of pain, 

inflammation, and swelling in appellant’s right wrist status post right carpal tunnel release.

Dr. Lopez expected that the requested device would accelerate his recovery and decrease his use 

of pain medication. On physical examination he found a well-healed surgical scar, no swelling, 

deformity, or tenderness, improving range of motion, 5/5 strength, and an intact neurovascular 

examination, but noted appellant’s complaint of continued right wrist pain, mostly after work.

Dr. Lopez did not provide medical rationale explaining how or why the requested device was in 

fact necessary to treat appellant’s accepted right carpal tunnel syndrome particularly in light of a

lack of objective findings. Medical evidence that states a conclusion, but does not offer a 

rationalized medical explanation regarding the cause of an employee’s condition is of limited 

probative value on the issue of causal relationship.8 The Board finds that Dr. Lopez failed to 

provide a rationalized opinion and, thus, OWCP did not abuse its discretion in denying his request 

for authorization.

9

In a December 9, 2019 report, the DMA reviewed the SOAF and Dr. Lopez’s report. While 

he noted that the medical device requested by Dr. Lopez was intended to treat the accepted carpal 

tunnel syndrome condition, he opined that it was not medically warranted. The DMA explained 

that the medical device was not supported by evidenced-based guidelines and there was no 

indication that it would improve appellant’s condition. Furthermore, he explained that Dr. Lopez’s 

examination revealed no objective physical findings that required additional treatment, noting his 

findings of no swelling, tenderness, or weakness. The DMA’s opinion was also based on a 

complete factual background, SOAF, and a review of the medical record. As such, his opinion 

represents the weight of the medical evidence with respect to the requested medical device.

10

As noted, the only restriction on OWCP’s authority to authorize medical treatment is one 

of reasonableness.11 OWCP obtained a well-rationalized report from its DMA in which he opined 

that the requested PEMF therapy device was not medically warranted to treat appellant’s accepted 

right carpal tunnel syndrome condition. It, therefore, did not abuse its discretion in denying 

authorization for the PEMF therapy device.

Appellant may submit new evidence or argument with a written request for reconsideration 

to OWCP within one year of this merit decision, pursuant to 5 U.S.C. § 8128(a) and 20 C.F.R. 

§§ 10.605 through 10.607.

 

8 M.M., Docket No. 19-0491 (issued August 14, 2019); G.V., Docket No. 18-0482 (issued May 21, 2019).

9 See P.L., Docket No. 18-0260 (issued April 14, 2020); L.S. Docket No. 18-1746 (issued April 9, 2019).

10 See J.O., Docket No. 19-0326 (issued July 16, 2019); J.R., Docket No. 17-1523 (April 3, 2018); M.B., Docket 

No. 17-1679 (issued February 8, 2018).

11 See supra note 5.
5

CONCLUSION

The Board finds that OWCP properly exercised its discretion in denying authorization for 

a PEMF therapy device.

ORDER

IT IS HEREBY ORDERED THAT the December 19, 2019 decision of the Office of 

Workers’ Compensation Programs is affirmed.

Issued: July 16, 2020

Washington, DC

Alec J. Koromilas, Chief Judge

Employees’ Compensation Appeals Board

Janice B. Askin, Judge

Employees’ Compensation Appeals Board

Patricia H. Fitzgerald, Alternate Judge

Employees’ Compensation Appeals Board